LEXARIA BIOSCIENCE CORP.— Sankey Diagram
Annual mode · period ending 2026-02-28 · SEC EDGAR
FY2026 - Q4(Dec 25 · Jan 26 · Feb 26)
Total Assets
$6M
↓-25.2% -$2Mvs FY2025
Total Liabilities
$277K
↓-85.5% -$2Mvs FY2025
Equity
$7M
↓-2.3% -$158Kvs FY2025
Cash
$5M
↓-21.5% -$1Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $6M | $9M |
| Current Assets | $6M | $8M |
| Cash | $5M | $7M |
| ST Investments | $141K | $74K |
| Receivables | $42K | $331K |
| Inventory | $0 | $0 |
| Other Current | $487K | $819K |
| Non-Current Assets | $717K | $953K |
| PPE | $243K | $262K |
| Goodwill | $0 | $0 |
| Intangibles | $318K | $506K |
| Investments | $0 | $0 |
| Other Non-Current | $156K | $185K |
| Total Liab+Eq | $7M | $9M |
| Current Liab. | $215K | $2M |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $215K | $2M |
| Non-Current Liab. | $62K | $94K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $62K | $94K |
| Equity | $7M | $7M |
| Retained Earnings | $67M | $57M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · LEXX · Comparing FY2026 vs FY2025